Breast cancer after ovarian cancer in BRCA mutation carriers

被引：0
|
作者：
Nanez, A. [1 ]
Powell, C. B. [2 ]
Garcia, C. [3 ]
机构：
[1] Kaiser Permanente San Francisco, San Francisco, CA USA
[2] Kaiser Permanente Northern Calif, San Francisco, CA USA
[3] Kaiser Permanente Northern Calif Gynecol Oncol Gr, San Francisco, CA USA
来源：
GYNECOLOGIC ONCOLOGY | 2020年 / 159卷
关键词：
D O I：
10.1016/j.ygyno.2020.05.440
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
552
引用
收藏
页码：256 / 256
页数：1
相关论文
共 50 条
  • [1] Effect of Breast Cancer After Ovarian Cancer on Mortality for BRCA Mutation Carriers
    Kim, John Y. S.
    JAMA SURGERY, 2015, 150 (05) : 492 - 492
  • [2] Breast Cancer Following Ovarian Cancer in BRCA Mutation Carriers
    Gangi, Alexandra
    Cass, Ilana
    Paik, Daniel
    Barmparas, Galinos
    Karlan, Beth
    Dang, Catherine
    Li, Andrew
    Walsh, Christine
    Rimel, Bobbie J.
    Amersi, Farin F.
    JAMA SURGERY, 2014, 149 (12) : 1306 - 1313
  • [3] Effect of Breast Cancer After Ovarian Cancer on Mortality for BRCA Mutation Carriers Reply
    Gangi, Alexandra
    Baramparas, Galinos
    Amersi, Farin F.
    JAMA SURGERY, 2015, 150 (05) : 491 - 492
  • [4] Breast Cancer Surveillance Following Ovarian Cancer in BRCA Mutation Carriers
    Fong, Abigail
    Cass, Ilana
    John, Catherine
    Gillen, Jessica
    Moore, Kathleen M.
    Gangi, Alexandra
    Walsh, Christine
    Li, Andrew J.
    Rimel, Bobbie J.
    Karlan, Beth Y.
    Amersi, Farin
    AMERICAN SURGEON, 2020, 86 (10) : 1243 - 1247
  • [5] Breast cancer surveillance following ovarian cancer in BRCA mutation carriers
    John, Catherine S.
    Fong, Abigail
    Alban, Rodrigo
    Gillen, Jessica
    Moore, Kathleen M.
    Walsh, Christine S.
    Li, Andrew J.
    Rimel, B. J.
    Amersi, Farin
    Cass, Ilana
    GYNECOLOGIC ONCOLOGY, 2022, 164 (01) : 202 - 207
  • [6] Breast cancer surveillance following ovarian cancer in BRCA mutation carriers
    Cass, I.
    John, C.
    Gillen, J.
    Moore, K. N.
    Walsh, C.
    Li, A. J.
    Rimel, B. J.
    Karlan, B. Y.
    Amersi, F.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 212 - 213
  • [7] Breast cancer risk in BRCA mutation carriers after diagnosis of epithelial ovarian cancer is lower than in carriers without ovarian cancer
    Nanez, Andrea
    Stram, Douglas A.
    Powell, C. Bethan
    Garcia, Christine
    GYNECOLOGIC ONCOLOGY REPORTS, 2022, 39
  • [8] Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
    Leendert H Zaaijer
    Helena C van Doorn
    Marian J E Mourits
    Marc van Beurden
    Joanne A de Hullu
    Muriel A Adank
    Luc R C W van Lonkhuijzen
    Hans F A Vasen
    Brigitte F M Slangen
    Katja N Gaarenstroom
    Ronald P Zweemer
    Peggy M L H Vencken
    Caroline Seynaeve
    Mieke Kriege
    British Journal of Cancer, 2016, 115 : 1174 - 1178
  • [9] Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
    Zaaijer, Leendert H.
    van Doorn, Helena C.
    Mourits, Marian J. E.
    van Beurden, Marc
    de Hullu, Joanne A.
    Adank, Muriel A.
    van Lonkhuijzen, Luc R. C. W.
    Vasen, Hans F. A.
    Slangen, Brigitte F. M.
    Gaarenstroom, Katja N.
    Zweemer, Ronald P.
    Vencken, Peggy M. L. H.
    Seynaeve, Caroline
    Kriege, Mieke
    BRITISH JOURNAL OF CANCER, 2016, 115 (10) : 1174 - 1178
  • [10] Risk of breast cancer after a diagnosis of ovarian cancer in BRCA mutation carriers: Is preventive mastectomy warranted?
    Mcgee, Jacob
    Giannakeas, Vasily
    Karlan, Beth
    Lubinski, Jan
    Gronwald, Jacek
    Rosen, Barry
    McLaughlin, John
    Risch, Harvey
    Sun, Ping
    Foulkes, William D.
    Neuhausen, Susan L.
    Kotsopoulos, Joanne
    Narod, Steven A.
    GYNECOLOGIC ONCOLOGY, 2017, 145 (02) : 346 - 351
12345